I certainly am not putting this stock down I have been invested with KSX/ISN for close on 2 years now
I was one of the first to applaud the hiring of the new CEO Michael Thomas a man with a great background
He says he has a great team around him and that may certainly be true, but as investors we haven sen the SP diminishing month by month lately
I recall posters here saying that Australia does not pay much interest to small biotech stocks and that as soon as we list on the OTC exchange the yanks will climb onboard as they have a far greater awareness of health related stocks
And the company has mentioned in Announcements that to list on the OTC will create interest and value for US investors
Right now that has not happened and I am getting fidgety about my investment after 2 years of hoping things would start to improve
Guess i'll hang on for a little longer for surely some Announcement about the MOU and partnership has to come soon
We live and hope
ISN Price at posting:
10.0¢ Sentiment: Hold Disclosure: Held